<?xml version="1.0" encoding="utf-8"?>
<!--Generated by DFIN XBRL Instance Document - http://www.dfinsolutions.com/ - Version R3.0 - on 18-August-2023 [09:07:36] {PM}-->
<schema targetNamespace="http://www.aqxpharma.com/20230630" elementFormDefault="qualified" xmlns:nltx="http://www.aqxpharma.com/20230630" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:us-gaap="http://fasb.org/us-gaap/2023" xmlns:country="http://xbrl.sec.gov/country/2023" xmlns:currency="http://xbrl.sec.gov/currency/2023" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:exch="http://xbrl.sec.gov/exch/2023" xmlns:naics="http://xbrl.sec.gov/naics/2023" xmlns:sic="http://xbrl.sec.gov/sic/2023" xmlns:us-types="http://fasb.org/us-types/2023" xmlns:stpr="http://xbrl.sec.gov/stpr/2023" xmlns:deprecated="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" xmlns:srt="http://fasb.org/srt/2023" xmlns:srt-types="http://fasb.org/srt-types/2023" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21">
<annotation>
<appinfo>
<link:roleType roleURI="http://www.aqxpharma.com/role/CoverPage" id="CoverPage">
<link:definition>1001 - Document -  Cover Page</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CondensedBalanceSheets" id="CondensedBalanceSheets">
<link:definition>1002 - Statement - Condensed Balance Sheets</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CondensedBalanceSheetsParenthetical" id="CondensedBalanceSheetsParenthetical">
<link:definition>1003 - Statement - Condensed Balance Sheets (Parenthetical)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CondensedStatementsOfOperationsAndComprehensiveIncomeLoss" id="CondensedStatementsOfOperationsAndComprehensiveIncomeLoss">
<link:definition>1004 - Statement - Condensed Statements of Operations and Comprehensive Income (Loss)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CondensedStatementsOfCashFlows" id="CondensedStatementsOfCashFlows">
<link:definition>1005 - Statement - Condensed Statements of Cash Flows</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CondensedStatementsOfStockholdersEquity" id="CondensedStatementsOfStockholdersEquity">
<link:definition>1006 - Statement - Condensed Statements of Stockholders' Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/NatureOfOperations" id="NatureOfOperations">
<link:definition>1007 - Disclosure - Nature of operations</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SummaryOfSignificantAccountingPolicies" id="SummaryOfSignificantAccountingPolicies">
<link:definition>1008 - Disclosure - Summary of significant accounting policies</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CashCashEquivalentsAndRestrictedCash" id="CashCashEquivalentsAndRestrictedCash">
<link:definition>1009 - Disclosure - Cash, cash equivalents, and restricted cash</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/Investments" id="Investments">
<link:definition>1010 - Disclosure - Investments</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/PropertyAndEquipmentNet" id="PropertyAndEquipmentNet">
<link:definition>1011 - Disclosure - Property and equipment, net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IntangibleAssetNet" id="IntangibleAssetNet">
<link:definition>1012 - Disclosure - Intangible asset, net</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/AccountsPayableAndOtherLiabilities" id="AccountsPayableAndOtherLiabilities">
<link:definition>1013 - Disclosure -  Accounts payable and other liabilities</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/Leases" id="Leases">
<link:definition>1014 - Disclosure -  Leases</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/Equity" id="Equity">
<link:definition>1015 - Disclosure - Equity</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/NetLossPerShare" id="NetLossPerShare">
<link:definition>1016 - Disclosure - Net loss per share</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IncomeTaxes" id="IncomeTaxes">
<link:definition>1017 - Disclosure - Income taxes</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LicenseAndPatentAgreements" id="LicenseAndPatentAgreements">
<link:definition>1018 - Disclosure - License and patent agreements</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/KPlan" id="KPlan">
<link:definition>1019 - Disclosure - 401(k) plan</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/RestructuringsAndImpairmentCharges" id="RestructuringsAndImpairmentCharges">
<link:definition>1020 - Disclosure - Restructurings and impairment charges</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SubsequentEvents" id="SubsequentEvents">
<link:definition>1021 - Disclosure - Subsequent Events</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SummaryOfSignificantAccountingPoliciesPolicies" id="SummaryOfSignificantAccountingPoliciesPolicies">
<link:definition>1022 - Disclosure - Summary of significant accounting policies (Policies)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SummaryOfSignificantAccountingPoliciesTables" id="SummaryOfSignificantAccountingPoliciesTables">
<link:definition>1023 - Disclosure - Summary of significant accounting policies (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CashCashEquivalentsAndRestrictedCashTables" id="CashCashEquivalentsAndRestrictedCashTables">
<link:definition>1024 - Disclosure - Cash, cash equivalents, and restricted cash (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/InvestmentsTables" id="InvestmentsTables">
<link:definition>1025 - Disclosure - Investments (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/PropertyAndEquipmentNetTables" id="PropertyAndEquipmentNetTables">
<link:definition>1026 - Disclosure -  Property and equipment, net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IntangibleAssetNetTables" id="IntangibleAssetNetTables">
<link:definition>1027 - Disclosure - Intangible asset, net (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/AccountsPayableAndOtherLiabilitiesTables" id="AccountsPayableAndOtherLiabilitiesTables">
<link:definition>1028 - Disclosure -  Accounts payable and other liabilities (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesTables" id="LeasesTables">
<link:definition>1029 - Disclosure -  Leases (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/StockholdersEquityTables" id="StockholdersEquityTables">
<link:definition>1030 - Disclosure -  Stockholders' equity (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/NetLossPerCommonStockTables" id="NetLossPerCommonStockTables">
<link:definition>1031 - Disclosure -  Net loss per common stock (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IncomeTaxesTables" id="IncomeTaxesTables">
<link:definition>1032 - Disclosure -  Income taxes (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/WorkforceReductionTables" id="WorkforceReductionTables">
<link:definition>1033 - Disclosure -  Workforce reduction (Tables)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails" id="SummaryOfSignificantAccountingPoliciesAdditionalInformationDetails">
<link:definition>1034 - Disclosure - Summary of significant accounting policies - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsAndRestrictedCashDetails" id="SummaryOfSignificantAccountingPoliciesCashAndCashEquivalentsAndRestrictedCashDetails">
<link:definition>1035 - Disclosure - Summary of significant accounting policies - Cash and cash equivalents and restricted cash (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SummaryOfSignificantAccountingPoliciesFairValueDetails" id="SummaryOfSignificantAccountingPoliciesFairValueDetails">
<link:definition>1036 - Disclosure - Summary of significant accounting policies - Fair Value (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CashCashEquivalentsAndRestrictedCashScheduleOfCashCashEquivalentsAndRestrictedCashDetails" id="CashCashEquivalentsAndRestrictedCashScheduleOfCashCashEquivalentsAndRestrictedCashDetails">
<link:definition>1037 - Disclosure - Cash, cash equivalents, and restricted cash - Schedule of Cash, Cash Equivalents, and Restricted Cash (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/CashCashEquivalentsAndRestrictedCashAdditionalInformationDetails" id="CashCashEquivalentsAndRestrictedCashAdditionalInformationDetails">
<link:definition>1038 - Disclosure - Cash, cash equivalents, and restricted cash - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/InvestmentsDetails" id="InvestmentsDetails">
<link:definition>1039 - Disclosure - Investments (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails" id="PropertyAndEquipmentNetScheduleOfPropertyAndEquipmentDetails">
<link:definition>1040 - Disclosure - Property and equipment, net - Schedule of Property and Equipment (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/PropertyAndEquipmentNetAdditionalInformationDetails" id="PropertyAndEquipmentNetAdditionalInformationDetails">
<link:definition>1041 - Disclosure - Property and equipment, net - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IntangibleAssetNetSummaryOfIntangibleAssetDetails" id="IntangibleAssetNetSummaryOfIntangibleAssetDetails">
<link:definition>1042 - Disclosure - Intangible asset, net - Summary of Intangible Asset (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/AccountsPayableAndOtherLiabilitiesScheduleOfAccountsPayableAndOtherLiabilitiesDetails" id="AccountsPayableAndOtherLiabilitiesScheduleOfAccountsPayableAndOtherLiabilitiesDetails">
<link:definition>1043 - Disclosure -  Accounts payable and other liabilities - Schedule of Accounts Payable and Other Liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesAdditionalInformationDetails" id="LeasesAdditionalInformationDetails">
<link:definition>1044 - Disclosure -  Leases - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesScheduleOfComponentsOfLeaseExpenseDetails" id="LeasesScheduleOfComponentsOfLeaseExpenseDetails">
<link:definition>1045 - Disclosure -  Leases - Schedule of Components of Lease Expense (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails" id="LeasesSupplementalBalanceSheetInformationRelatedToLeasesDetails">
<link:definition>1046 - Disclosure -  Leases - Supplemental Balance Sheet Information Related to Leases (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesSupplementalCashFlowInformationRelatedToLeasesDetails" id="LeasesSupplementalCashFlowInformationRelatedToLeasesDetails">
<link:definition>1047 - Disclosure -  Leases - Supplemental Cash flow Information Related to Leases (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesScheduleOfCompanysOperatingAndFinanceLeaseLiabilitiesDetails" id="LeasesScheduleOfCompanysOperatingAndFinanceLeaseLiabilitiesDetails">
<link:definition>1048 - Disclosure -  Leases - Schedule of Company's Operating and Finance Lease Liabilities (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/EquityAdditionalInformationDetails" id="EquityAdditionalInformationDetails">
<link:definition>1049 - Disclosure - Equity - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/EquityScheduleOfStockOptionActivityDetails" id="EquityScheduleOfStockOptionActivityDetails">
<link:definition>1050 - Disclosure - Equity - Schedule of Stock Option Activity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/EquityScheduleOfWeightedAverageAssumptionsDetails" id="EquityScheduleOfWeightedAverageAssumptionsDetails">
<link:definition>1051 - Disclosure - Equity - Schedule of Weighted Average Assumptions (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/EquityScheduleOfRsuActivityDetails" id="EquityScheduleOfRsuActivityDetails">
<link:definition>1052 - Disclosure - Equity - Schedule of RSU Activity (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/EquitySummaryOfStockBasedCompensationExpenseDetails" id="EquitySummaryOfStockBasedCompensationExpenseDetails">
<link:definition>1053 - Disclosure - Equity - Summary of Stock-based Compensation Expense (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/NetLossPerShareScheduleOfSecuritiesExcludedFromComputationOfEarningsPerShareDetails" id="NetLossPerShareScheduleOfSecuritiesExcludedFromComputationOfEarningsPerShareDetails">
<link:definition>1054 - Disclosure - Net loss per share - Schedule of Securities Excluded From Computation of Earnings Per Share (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IncomeTaxesScheduleOfIncomeTaxRecoveryDetails" id="IncomeTaxesScheduleOfIncomeTaxRecoveryDetails">
<link:definition>1055 - Disclosure -  Income taxes - Schedule of Income Tax Recovery (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IncomeTaxesScheduleOfNetLossIncomeBeforeTaxesDetails" id="IncomeTaxesScheduleOfNetLossIncomeBeforeTaxesDetails">
<link:definition>1056 - Disclosure -  Income taxes - Schedule of Net (Loss) Income Before Taxes (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IncomeTaxesComponentsOfDeferredIncomeTaxAssetsDetails" id="IncomeTaxesComponentsOfDeferredIncomeTaxAssetsDetails">
<link:definition>1057 - Disclosure -  Income taxes - Components of Deferred Income Tax Assets (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/IncomeTaxesAdditionalInformationDetails" id="IncomeTaxesAdditionalInformationDetails">
<link:definition>1058 - Disclosure -  Income taxes - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LicenseAndPatentAgreementsAdditionalInformationDetails" id="LicenseAndPatentAgreementsAdditionalInformationDetails">
<link:definition>1059 - Disclosure - License and patent agreements - Additional Information (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/RestructuringsAndImpairmentChargesDetails" id="RestructuringsAndImpairmentChargesDetails">
<link:definition>1060 - Disclosure -  Restructurings and impairment charges (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/SubsequentEventsDetails" id="SubsequentEventsDetails">
<link:definition>1061 - Disclosure -  Subsequent Events (Details)</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:roleType roleURI="http://www.aqxpharma.com/role/LeasesScheduleOfCompanysOperatingAndFinanceLeaseLiabilitiesDetailsAlternate1" id="LeasesScheduleOfCompanysOperatingAndFinanceLeaseLiabilitiesDetailsAlternate1">
<link:definition>1062 - Statement -  Leases - Schedule of Company's Operating and Finance Lease Liabilities (Details) Alternate 1</link:definition>
<link:usedOn>link:presentationLink</link:usedOn>
<link:usedOn>link:definitionLink</link:usedOn>
<link:usedOn>link:calculationLink</link:usedOn>
</link:roleType>
<link:linkbaseRef xlink:type="simple" xlink:href="nltx-20230630_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="nltx-20230630_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="nltx-20230630_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
<link:linkbaseRef xlink:type="simple" xlink:href="nltx-20230630_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
</appinfo>
</annotation>
<import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
<import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
<import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
<import namespace="http://fasb.org/us-gaap/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd" />
<import namespace="http://xbrl.sec.gov/country/2023" schemaLocation="https://xbrl.sec.gov/country/2023/country-2023.xsd" />
<import namespace="http://xbrl.sec.gov/currency/2023" schemaLocation="https://xbrl.sec.gov/currency/2023/currency-2023.xsd" />
<import namespace="http://xbrl.sec.gov/exch/2023" schemaLocation="https://xbrl.sec.gov/exch/2023/exch-2023.xsd" />
<import namespace="http://xbrl.sec.gov/naics/2023" schemaLocation="https://xbrl.sec.gov/naics/2023/naics-2023.xsd" />
<import namespace="http://xbrl.sec.gov/sic/2023" schemaLocation="https://xbrl.sec.gov/sic/2023/sic-2023.xsd" />
<import namespace="http://xbrl.sec.gov/stpr/2023" schemaLocation="https://xbrl.sec.gov/stpr/2023/stpr-2023.xsd" />
<import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
<import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
<import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd" />
<import namespace="http://fasb.org/us-types/2023" schemaLocation="https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd" />
<import namespace="http://fasb.org/srt-types/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd" />
<import namespace="http://fasb.org/srt/2023" schemaLocation="https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd" />
<import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
<element name="StockIssuedDuringPeriodSharesPreFundedWarrants" type="xbrli:sharesItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_StockIssuedDuringPeriodSharesPreFundedWarrants" substitutionGroup="xbrli:item" />
<element name="PreFundedWarrantsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_PreFundedWarrantsMember" substitutionGroup="xbrli:item" />
<element name="CashCashEquivalentsAndRestrictedCash1DisclosureTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_CashCashEquivalentsAndRestrictedCash1DisclosureTextBlock" substitutionGroup="xbrli:item" />
<element name="LicenseAgreementAbstract" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_LicenseAgreementAbstract" substitutionGroup="xbrli:item" />
<element name="LicenseAgreementDisclosureTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_LicenseAgreementDisclosureTextBlock" substitutionGroup="xbrli:item" />
<element name="ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock" type="dtr-types:textBlockItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_ScheduleOfSupplementalBalanceSheetInformationRelatedToLeasesTableTextBlock" substitutionGroup="xbrli:item" />
<element name="SignificantAccountingPoliciesTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_SignificantAccountingPoliciesTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="LaboratoryEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_LaboratoryEquipmentMember" substitutionGroup="xbrli:item" />
<element name="FurnitureFixturesAndITEquipmentMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_FurnitureFixturesAndITEquipmentMember" substitutionGroup="xbrli:item" />
<element name="AccruedClinicalExpensesCurrent" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_AccruedClinicalExpensesCurrent" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="OfficeSpaceAdditionalOfficesAndLaboratoryMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_OfficeSpaceAdditionalOfficesAndLaboratoryMember" substitutionGroup="xbrli:item" />
<element name="OfficeSpacePrincipalExecutiveOfficesAndLaboratoryMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_OfficeSpacePrincipalExecutiveOfficesAndLaboratoryMember" substitutionGroup="xbrli:item" />
<element name="OperatingLeaseSubleaseBaseLeasePayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_OperatingLeaseSubleaseBaseLeasePayments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="IncreaseDecreaseInOperatingLeaseRightOfUseAssets" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_IncreaseDecreaseInOperatingLeaseRightOfUseAssets" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="NumberOfOptionToExtendLease" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_NumberOfOptionToExtendLease" substitutionGroup="xbrli:item" />
<element name="TenantImprovementAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_TenantImprovementAllowance" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="FinanceLeasePrincipalAndInterestPayments" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_FinanceLeasePrincipalAndInterestPayments" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="StockIncentivePlanTwoThousandFourteenMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_StockIncentivePlanTwoThousandFourteenMember" substitutionGroup="xbrli:item" />
<element name="EquityIncentivePlanTwoThousandSixMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_EquityIncentivePlanTwoThousandSixMember" substitutionGroup="xbrli:item" />
<element name="A2020EmployeeStockPurchasePlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_A2020EmployeeStockPurchasePlanMember" substitutionGroup="xbrli:item" />
<element name="EquityOfferingSalesAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_EquityOfferingSalesAgreementMember" substitutionGroup="xbrli:item" />
<element name="PercentageOfOutstandingStockPerStockholderMaximum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_PercentageOfOutstandingStockPerStockholderMaximum" substitutionGroup="xbrli:item" />
<element name="PercentageOfOutstandingStockPerStockholderUponNoticeMaximum" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_PercentageOfOutstandingStockPerStockholderUponNoticeMaximum" substitutionGroup="xbrli:item" />
<element name="ClassOfWarrantOrRightNoticePeriod" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_ClassOfWarrantOrRightNoticePeriod" substitutionGroup="xbrli:item" />
<element name="SaleOfStockMaximumAggregateOfferingPrice" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_SaleOfStockMaximumAggregateOfferingPrice" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" type="xbrli:durationItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_ShareBasedCompensationArrangementByShareBasedPaymentAwardPurchasePeriod" substitutionGroup="xbrli:item" />
<element name="StockBasedCompensationIncreaseInCommonStockIssuancePercentage" type="dtr-types:percentItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_StockBasedCompensationIncreaseInCommonStockIssuancePercentage" substitutionGroup="xbrli:item" />
<element name="EmployeeStockPurchasePlanNumberOfOfferingPerYear" type="xbrli:integerItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_EmployeeStockPurchasePlanNumberOfOfferingPerYear" substitutionGroup="xbrli:item" />
<element name="DeferredTaxAssetsLeaseLiability" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_DeferredTaxAssetsLeaseLiability" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsCapitalizedResearchAndDevelopment" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_DeferredTaxAssetsCapitalizedResearchAndDevelopment" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="DeferredTaxAssetsBeforeValuationAllowance" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_DeferredTaxAssetsBeforeValuationAllowance" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="IncomeTaxesDisclosureTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_IncomeTaxesDisclosureTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="IncomeTaxesDisclosureLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_IncomeTaxesDisclosureLineItems" substitutionGroup="xbrli:item" />
<element name="OperatingLossCarryforwardsSubjectToExpiration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_OperatingLossCarryforwardsSubjectToExpiration" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="OperatingLossCarryforwardsNotSubjectToExpiration" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_OperatingLossCarryforwardsNotSubjectToExpiration" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="LicenseAndPatentAgreementsTable" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_LicenseAndPatentAgreementsTable" substitutionGroup="xbrldt:hypercubeItem" />
<element name="NonVotingConvertiblePreferredStockMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_NonVotingConvertiblePreferredStockMember" substitutionGroup="xbrli:item" />
<element name="LicenseAndPatentAgreementsLineItems" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_LicenseAndPatentAgreementsLineItems" substitutionGroup="xbrli:item" />
<element name="LicenseArrangementsAmountsPayableOnDevelopmentalMilestones" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_LicenseArrangementsAmountsPayableOnDevelopmentalMilestones" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="LicenseArrangementsAmountsPayableBasedOnNetSales" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_LicenseArrangementsAmountsPayableBasedOnNetSales" substitutionGroup="xbrli:item" xbrli:balance="credit" />
<element name="UniversityOfWashingtonMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_UniversityOfWashingtonMember" substitutionGroup="xbrli:item" />
<element name="March2023RestructuringPlanMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_March2023RestructuringPlanMember" substitutionGroup="xbrli:item" />
<element name="November2022ReductionsMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_November2022ReductionsMember" substitutionGroup="xbrli:item" />
<element name="NeurogeneMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_NeurogeneMember" substitutionGroup="xbrli:item" />
<element name="NeoleukinMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_NeoleukinMember" substitutionGroup="xbrli:item" />
<element name="RestructuringAndRelatedCostExpectedCostNonCashExpense" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_RestructuringAndRelatedCostExpectedCostNonCashExpense" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="BusinessCombinationReimbursementOfExpenses" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="duration" nillable="true" id="nltx_BusinessCombinationReimbursementOfExpenses" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="BusinessCombinationTerminationFee" type="xbrli:monetaryItemType" abstract="false" xbrli:periodType="instant" nillable="true" id="nltx_BusinessCombinationTerminationFee" substitutionGroup="xbrli:item" xbrli:balance="debit" />
<element name="AgreementAxis" type="xbrli:stringItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_AgreementAxis" substitutionGroup="xbrldt:dimensionItem" />
<element name="AgreementDomain" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_AgreementDomain" substitutionGroup="xbrli:item" />
<element name="MergerAgreementMember" type="dtr-types:domainItemType" abstract="true" xbrli:periodType="duration" nillable="true" id="nltx_MergerAgreementMember" substitutionGroup="xbrli:item" />
</schema>
